In the brains of human patients and AD model mice, IL-33 and ST2 are respectively highly expressed in astrocytes in close proximity to APs and NFTs, whereby IL-33 may exacerbate the release of pro-inflammatory molecules from astrocytes and contribute to Aβ-induced cognitive deficits [51, 59]. This evidence concerns the gene IL33 and Cognitive impairment.